ELVN logo

Enliven Therapeutics (ELVN) Depreciation And Amortization

Annual D&A

$297.00 K
+$82.00 K+38.14%

December 31, 2023


Summary


Performance

ELVN Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

Quarterly D&A

$80.00 K
+$2000.00+2.56%

September 30, 2024


Summary


Performance

ELVN Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM D&A

$315.00 K
+$2000.00+0.64%

September 30, 2024


Summary


Performance

ELVN TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

ELVN Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+38.1%+1.3%+1.9%
3 y3 years+560.0%+19.4%+29.6%
5 y5 years+560.0%+19.4%+29.6%

ELVN Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+158.3%at high+105.1%at high+707.7%
5 y5-yearat high+560.0%at high+105.1%at high+707.7%
alltimeall timeat high+560.0%at high+105.1%at high+707.7%

Enliven Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$80.00 K(+2.6%)
$315.00 K(+0.6%)
Jun 2024
-
$78.00 K(-1.3%)
$313.00 K(+1.3%)
Mar 2024
-
$79.00 K(+1.3%)
$309.00 K(+4.0%)
Dec 2023
$297.00 K
$78.00 K(0.0%)
$297.00 K(+4.9%)
Sep 2023
-
$78.00 K(+5.4%)
$283.00 K(+6.8%)
Jun 2023
-
$74.00 K(+10.4%)
$265.00 K(+9.1%)
DateAnnualQuarterlyTTM
Mar 2023
-
$67.00 K(+4.7%)
$243.00 K(+13.0%)
Dec 2022
$215.00 K(+87.0%)
$64.00 K(+6.7%)
$215.00 K(+42.4%)
Sep 2022
-
$60.00 K(+15.4%)
$151.00 K(+65.9%)
Jun 2022
-
$52.00 K(+33.3%)
$91.00 K(+133.3%)
Mar 2022
-
$39.00 K
$39.00 K
Dec 2021
$115.00 K(+155.6%)
-
-
Dec 2020
$45.00 K
-
-

FAQ

  • What is Enliven Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Enliven Therapeutics?
  • What is Enliven Therapeutics annual D&A year-on-year change?
  • What is Enliven Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Enliven Therapeutics?
  • What is Enliven Therapeutics quarterly D&A year-on-year change?
  • What is Enliven Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Enliven Therapeutics?
  • What is Enliven Therapeutics TTM D&A year-on-year change?

What is Enliven Therapeutics annual depreciation & amortization?

The current annual D&A of ELVN is $297.00 K

What is the all time high annual D&A for Enliven Therapeutics?

Enliven Therapeutics all-time high annual depreciation & amortization is $297.00 K

What is Enliven Therapeutics annual D&A year-on-year change?

Over the past year, ELVN annual depreciation & amortization has changed by +$82.00 K (+38.14%)

What is Enliven Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of ELVN is $80.00 K

What is the all time high quarterly D&A for Enliven Therapeutics?

Enliven Therapeutics all-time high quarterly depreciation & amortization is $80.00 K

What is Enliven Therapeutics quarterly D&A year-on-year change?

Over the past year, ELVN quarterly depreciation & amortization has changed by +$1000.00 (+1.27%)

What is Enliven Therapeutics TTM depreciation & amortization?

The current TTM D&A of ELVN is $315.00 K

What is the all time high TTM D&A for Enliven Therapeutics?

Enliven Therapeutics all-time high TTM depreciation & amortization is $315.00 K

What is Enliven Therapeutics TTM D&A year-on-year change?

Over the past year, ELVN TTM depreciation & amortization has changed by +$6000.00 (+1.94%)